Literature DB >> 7841827

Results of the DCCT trial. Implications for managing our patients with diabetes.

G Worrall1.   

Abstract

Results of the Diabetes Control and Complications Trial (DDCT) suggest that intensive therapy can prevent or delay the microvascular complications of diabetes. This article critically appraises evidence from the DCCT and other prospective trials and concludes that the successful results for persons with insulin-dependent diabetes cannot be generalized to most family practice diabetes patients, who have non-insulin-dependent diabetes.

Entities:  

Mesh：

Year:  1994        PMID： 7841827      PMCID： PMC2380238     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  24 in total

1.  Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; K F Hanssen; T Ganes; P Kierulf; E Smeland; L Sandvik; O Aagenaes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 2.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

3.  Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS).

Authors:  P Reichard; A Britz; P Carlsson; I Cars; L Lindblad; B Y Nilsson; U Rosenqvist
Journal:  J Intern Med       Date:  1990-11       Impact factor: 8.989

4.  The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.

Authors: 
Journal:  Diabetes       Date:  1986-05       Impact factor: 9.461

5.  Increased nerve conduction in diabetics after a year of improved glucoregulation.

Authors:  A L Ehle; P Raskin
Journal:  J Neurol Sci       Date:  1986-07       Impact factor: 3.181

6.  Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).

Authors:  T Olsen; B Richelsen; N Ehlers; H Beck-Nielsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-04

7.  Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes.

Authors:  J Jakobsen; J S Christiansen; I Kristoffersen; C K Christensen; K Hermansen; A Schmitz; C E Mogensen
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

Review 8.  Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus.

Authors:  R G Nelson; J E Everhart; W C Knowler; P H Bennett
Journal:  Prim Care       Date:  1988-06       Impact factor: 2.907

9.  Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

10.  Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM.

Authors:  H Beck-Nielsen; B Richelsen; C E Mogensen; T Olsen; N Ehlers; C B Nielsen; P Charles
Journal:  Diabetes Care       Date:  1985 Nov-Dec       Impact factor: 19.112
View more
  3 in total

1.  Intensified metabolic control in insulin-dependent diabetes mellitus.

Authors:  J Dupre
Journal:  Can Fam Physician       Date:  1995-01       Impact factor: 3.275

2.  Glomerular diseases outcome at one year in a tertiary care centre.

Authors:  Huma Mamun Mahmud; Darshan Kumar; Humera Irum; Syed Farman Ali
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

Review 3.  A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists.

Authors:  Shamala Ayadurai; H Laetitia Hattingh; Lisa B G Tee; Siti Norlina Md Said
Journal:  J Diabetes Res       Date:  2016-05-10       Impact factor: 4.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.